Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease

[1]  P. Deyn,et al.  Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease? , 2015, Cortex.

[2]  R. Nixon,et al.  Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease , 2015, Molecular Psychiatry.

[3]  R. Nixon,et al.  Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease , 2015, Experimental Neurology.

[4]  H. C. Cromwell,et al.  Influence of emotional states on inhibitory gating: Animals models to clinical neurophysiology , 2015, Behavioural Brain Research.

[5]  P. Murali Doraiswamy,et al.  When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer’s Disease , 2014, Front. Neurol..

[6]  John Apergis-Schoute,et al.  Left–right dissociation of hippocampal memory processes in mice , 2014, Proceedings of the National Academy of Sciences.

[7]  Rena Li,et al.  Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.

[8]  P. Wong,et al.  Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects , 2014, Journal of neurochemistry.

[9]  J. Cirrito,et al.  Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.

[10]  F. Schmitt,et al.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..

[11]  T. Suhara,et al.  Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau , 2014, Front. Neurol..

[12]  P. Vemuri,et al.  Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.

[13]  Michael J. Yetman,et al.  Wild-Type Neural Progenitors Divide and Differentiate Normally in an Amyloid-Rich Environment , 2013, The Journal of Neuroscience.

[14]  Dexter L. Lee,et al.  Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice , 2013, Molecular Neurodegeneration.

[15]  J. Weuve,et al.  Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.

[16]  Hongkui Zeng,et al.  Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus , 2013, Neuron.

[17]  D. Borchelt,et al.  Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis , 2013, The Journal of Neuroscience.

[18]  Michael J. Yetman,et al.  Strain Background Influences Neurotoxicity and Behavioral Abnormalities in Mice Expressing the Tetracycline Transactivator , 2012, The Journal of Neuroscience.

[19]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[20]  J. Jankowsky,et al.  Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult , 2012, Molecular Neurodegeneration.

[21]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[22]  L. D’Adamio,et al.  Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia , 2012, Molecular Neurodegeneration.

[23]  Y. Shitaka,et al.  Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice , 2012, The Journal of Neuroscience.

[24]  O. Arancio,et al.  β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia , 2012, Molecular Neurodegeneration.

[25]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[26]  David S. Miller,et al.  Neuropsychiatric symptoms in Alzheimer’s disease , 2011, Alzheimer's & Dementia.

[27]  Dinggang Shen,et al.  Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI , 2011, NeuroImage.

[28]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[29]  E. Mufson,et al.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice , 2011, Neurobiology of Disease.

[30]  Todd E. Golde,et al.  Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift , 2011, Neuron.

[31]  Karl Herrup,et al.  Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.

[32]  Li-Huei Tsai,et al.  Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis , 2010, The Journal of Neuroscience.

[33]  Andrew M. Poulos,et al.  Compensation in the neural circuitry of fear conditioning awakens learning circuits in the bed nuclei of the stria terminalis , 2010, Proceedings of the National Academy of Sciences.

[34]  Michael W. Weiner,et al.  Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans , 2010, Neurobiology of Aging.

[35]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[36]  Andre Rupp,et al.  P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function , 2010, Neurobiology of Aging.

[37]  Thomas J. Wills,et al.  Environmental novelty elicits a later theta phase of firing in CA1 but not subiculum , 2010, Hippocampus.

[38]  Hong-wei Dong,et al.  Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures? , 2010, Neuron.

[39]  M. Geyer,et al.  Prepulse inhibition and genetic mouse models of schizophrenia , 2009, Behavioural Brain Research.

[40]  Susumu Tonegawa,et al.  CA3 NMDA receptors are required for the rapid formation of a salient contextual representation , 2009, Hippocampus.

[41]  R. Kesner,et al.  The role of the dentate gyrus, CA3a,b, and CA3c for detecting spatial and environmental novelty , 2008, Hippocampus.

[42]  Paul S. Aisen,et al.  Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model , 2008, Brain Research.

[43]  D. Price,et al.  Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice , 2008, Proceedings of the National Academy of Sciences.

[44]  Guoping Feng,et al.  3D‐reconstruction and functional properties of GFP‐positive and GFP‐negative granule cells in the fascia dentata of the Thy1‐GFP mouse , 2008, Hippocampus.

[45]  H. C. Cromwell,et al.  Sensory Gating: A Translational Effort from Basic to Clinical Science , 2008, Clinical EEG and neuroscience.

[46]  D. Ingram,et al.  Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease , 2008, Neuroscience.

[47]  Susumu Tonegawa,et al.  Transgenic Inhibition of Synaptic Transmission Reveals Role of CA3 Output in Hippocampal Learning , 2008, Science.

[48]  R. Kesner.  Behavioral functions of the CA3 subregion of the hippocampus. , 2007, Learning & memory.

[49]  J. D. McGaugh,et al.  Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice , 2007, Neurobiology of Disease.

[50]  Rene Hen,et al.  Adult hippocampal neurogenesis in depression , 2007, Nature Neuroscience.

[51]  C. Rampon,et al.  Alzheimer's-Type Amyloidosis in Transgenic Mice Impairs Survival of Newborn Neurons Derived from Adult Hippocampal Neurogenesis , 2007, The Journal of Neuroscience.

[52]  A. Savonenko,et al.  Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern , 2006, Neuroscience.

[53]  H. Lester,et al.  Open access, freely available online PLoS MEDICINE Persistent Amyloidosis following Suppression of Ab Production in a Transgenic Model of Alzheimer Disease , 2022 .

[54]  David A Bennett,et al.  Sex differences in the clinical manifestations of Alzheimer disease pathology. , 2005, Archives of general psychiatry.

[55]  D. Borchelt,et al.  Environmental Enrichment Mitigates Cognitive Deficits in a Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[56]  D. Borchelt,et al.  Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities , 2005, Neurobiology of Disease.

[57]  Matthew P. Frosch,et al.  The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease , 2004, Neuron.

[58]  M. Hutton,et al.  Clearing Tau Pathology with Aβ Immunotherapy—Reversible and Irreversible Stages Revealed , 2004, Neuron.

[59]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[60]  Heikki Tanila,et al.  Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice , 2003, Neurobiology of Disease.

[61]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[62]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  G. Arendash,et al.  Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months , 2002, Physiology & Behavior.

[64]  B. Lamb,et al.  Neuropathological Characterization of Mutant Amyloid Precursor Protein Yeast Artificial Chromosome Transgenic Mice , 2001, Neurobiology of Disease.

[65]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[66]  F. Bian,et al.  Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.

[67]  H. Soininen,et al.  The load and distribution of β‐amyloid in brain tissue of patients with Alzheimer's disease , 2001, Acta neurologica Scandinavica.

[68]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[69]  G. Koob,et al.  Genetic Differences in Response to Novelty and Spatial Memory Using a Two-Trial Recognition Task in Mice , 2000, Neurobiology of Learning and Memory.

[70]  G. Arendash,et al.  Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease , 1999, Behavioural Brain Research.

[71]  E R Kandel,et al.  Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  D L Price,et al.  A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.

[73]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[74]  J. Mills,et al.  Sex differences in learning and memory in mice: effects of sequence of testing and cholinergic blockade. , 1995, Behavioral neuroscience.

[75]  D. Amaral,et al.  The three-dimensional organization of the hippocampal formation: A review of anatomical data , 1989, Neuroscience.

[76]  R. Schmidt,et al.  Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria). , 2015, Journal of Alzheimer's disease : JAD.

[77]  D. Amaral,et al.  The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). , 2007, Progress in brain research.

[78]  C. Janus,et al.  Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration , 2007, Behavior genetics.

[79]  T. Morikawa,et al.  Power evaluation of various modified Bonferroni procedures by a Monte Carlo study. , 1996, Journal of biopharmaceutical statistics.